What signs, symptoms, and monitoring parameters are indicated in propranolol toxicity (overdose)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Propranolol Toxicity: Signs, Symptoms, and Monitoring Parameters

In propranolol overdose, immediately monitor for cardiovascular collapse (bradycardia, hypotension), CNS toxicity (seizures, coma, altered mental status), and sodium channel blockade (wide QRS >100ms), as these are the hallmark features that distinguish propranolol from other beta-blockers and predict severe outcomes.

Key Clinical Manifestations

Cardiovascular Toxicity

Propranolol overdose produces distinctive cardiac effects that require immediate recognition 1:

  • Bradycardia (heart rate <50 bpm) - occurs in 20% of cases 2
  • Hypotension (systolic BP <90 mmHg) - occurs in 42% of cases, can develop with doses as low as 400mg in isolated ingestions 2
  • Cardiogenic shock requiring inotropic support in 20% of severe cases 2
  • Dysrhythmias including wide complex tachycardia and cardiac arrest 3

Central Nervous System Toxicity (Unique to Propranolol)

Because propranolol is highly lipophilic, it crosses the blood-brain barrier causing CNS effects that other beta-blockers typically do not 1:

  • Seizures - propranolol is the ONLY beta-blocker consistently associated with seizures; occurs in 8% of overdoses, with two-thirds of patients ingesting >2g developing seizures 2, 4
  • Coma - develops in 14% of cases 2
  • Altered mental status, delirium, confusion 1
  • CNS depression can occur BEFORE cardiac signs - this is a critical pitfall, as severe CNS toxicity may develop with normal vital signs initially 5

Sodium Channel Blockade

Propranolol has membrane-stabilizing (sodium channel blocking) properties 1:

  • QRS widening >100ms - occurs in 8% of cases and is significantly associated with seizure risk 2, 4
  • Wide complex tachycardia - an atypical but dangerous presentation 3

Other Manifestations

  • Bronchospasm - can occur even after cardiovascular parameters normalize 1
  • Hypoglycemia 1, 6
  • Hyperkalemia 1

Critical Monitoring Parameters

Immediate Assessment (First 6 Hours)

All toxic manifestations occur within 6 hours of ingestion for immediate-release formulations 1, 4. Monitor:

  1. Continuous cardiac monitoring for:

    • Heart rate and rhythm
    • Blood pressure every 15-30 minutes initially
    • ECG with specific attention to QRS duration (>100ms predicts seizures) 2, 4

  2. Neurological status every 30 minutes:

    • Level of consciousness (Glasgow Coma Scale)
    • Seizure activity
    • Mental status changes

  3. Laboratory monitoring 6:

    • Blood glucose (hypoglycemia risk)
    • Serum potassium (hyperkalemia)
    • Lactate (end-organ perfusion)
    • Renal function

  4. Respiratory status:

    • Respiratory rate and effort
    • Oxygen saturation
    • Need for airway protection if coma develops

Echocardiography

Early echocardiographic evaluation is critical - acute dilated cardiomyopathy can develop with normal vital signs initially 5. This is a commonly missed finding that delays appropriate treatment.

Dose-Toxicity Relationships

Severity Thresholds (Isolated Propranolol Ingestions)

Based on the largest prospective study 2:

  • 400mg: Lowest dose causing hypotension
  • 800mg: Lowest dose causing bradycardia
  • 2,000mg: Threshold for severe toxicity (seizures, coma, cardiac arrest)
  • ≥2,000mg: 53% develop severe toxicity
  • 2,400-16,000mg: Cardiac arrest range (3% of all cases)

Timeline

  • Within 2 hours: Cardiovascular symptoms typically appear 1
  • Up to 6 hours: Window for development of all toxic effects for immediate-release 1, 4
  • Up to 8 hours: Extended observation for sustained-release formulations 1

Common Pitfalls to Avoid

  1. Do NOT use ipecac - temporally associated with cardiorespiratory arrest in beta-blocker overdose 4

  2. Do NOT assume safety based on normal vital signs - severe CNS depression and dilated cardiomyopathy can develop before hemodynamic changes 5

  3. Do NOT use epinephrine for hypotension - may provoke uncontrolled hypertension due to unopposed alpha-receptor stimulation 6

  4. Do NOT discharge patients early - asymptomatic patients at 6 hours post-ingestion (immediate-release) are generally safe, but CNS and respiratory effects can occur later even with normal BP and ECG 1

  5. Watch for co-ingestions - 74% of propranolol overdoses involve other drugs (commonly benzodiazepines), which complicate the clinical picture 2

Treatment Monitoring

When administering antidotes, monitor response to 7, 6:

  • Glucagon (50-150 mcg/kg IV bolus, then 1-5 mg/hr infusion): Monitor for vomiting, improvement in heart rate and blood pressure
  • High-dose insulin (1 U/kg bolus, then 1-10 U/kg/hr): Monitor glucose, potassium, and volume status closely
  • Atropine (0.5-1mg IV): Monitor heart rate response
  • Calcium (2000mg calcium chloride IV): Monitor ionized calcium (keep 1.5-2x upper limit of normal), blood pressure

The median length of stay is 17 hours, with most patients requiring 11-32 hours of monitoring 2. Severe toxicity cases require ICU admission with continuous hemodynamic monitoring 8.

References

4
Research

Relative toxicity of beta blockers in overdose.

Journal of toxicology. Clinical toxicology, 1996

Related Questions

After accidentally taking a second 60 mg dose of extended‑release propranolol in one day, should I go to the emergency department?
Is an ingestion of 1200 mg propranolol (non-selective β‑blocker) potentially fatal?
Will ingestion of lorazepam 0.5 mg, clonidine 0.4 mg, and propranolol 0.5 mg be fatal?
In a 31‑year‑old woman on propranolol who experiences brief episodes of tachycardia 170–180 bpm with shortness of breath and oxygen saturation 89–90 % at rest (including while lying down), similar episodes occurred during a prior pregnancy and were previously attributed to anxiety; what is the likely etiology and what urgent cardiac evaluation and management steps are recommended?
What is the maximum dose of propranolol (beta‑blocker) for an adult with panic attacks who has no contraindications such as asthma, severe bradycardia, heart block, or uncontrolled heart failure?
In a female patient who is refusing oral olanzapine and received a long‑acting paliperidone injection two weeks ago, should oral olanzapine be restarted?
What platelet count is needed for a patient to safely have a regular diet?
Is haptoglobin level useful in diagnosing iron deficiency anemia, and how long does the complete blood count normalize after a patient begins daily oral iron supplementation?
What is the recommended adult dosing of glycopyrrolate for oral, intravenous, and pre‑operative use, including adjustments for renal impairment?
Can a patient on chronic dialysis take a glucagon‑like peptide‑1 (GLP‑1) receptor agonist?
What medication regimen, including dose and frequency, is recommended for treating anxiety in a patient with chronic obstructive pulmonary disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.